Recent advances in elucidating pain mechanisms

Current Opinion in Anaesthesiology

Volumn 18, Issue 5, 2005, Pages 540-547

  Vadivelu, Nalini ^a   Sinatra, Raymond ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Pain mechanisms; Pain modulation; Pain states

Indexed keywords

ANALGESIC AGENT; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; DIZOCILPINE; ETORICOXIB; GABAPENTIN; LUMIRACOXIB; MEMANTINE; MORPHINE SULFATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NERAMEXANE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; PREGABALIN; ROFECOXIB; VALDECOXIB;

ALLODYNIA; APOPTOSIS; CHRONIC PAIN; HUMAN; HYPERALGESIA; ION TRANSPORT; NERVE CELL LESION; NERVE CELL PLASTICITY; NOCICEPTION; PAIN; POSTOPERATIVE PAIN; PRIORITY JOURNAL; REVIEW; SENSITIZATION; SYNAPSE; THROMBOSIS; TISSUE INJURY;

EID: 26244432567     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aco.0000183109.27297.75     Document Type: Review

References (32)

1. Samad TA, Moore KA, Sapirstein A, et al. Interleukin-1 beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 2001; 410:471-475.
2. Dickenson AH, Suzuki R. Opioids in neuropathic pain: clues from animal studies. Eur J Pain 2005; 9:113-116. The importance of similar changes occurring in nerve and tissue damage is highlighted in this paper.
3. Danysz W, Parsons CG, Quack G. NMDA channel blockers: memantine and amino-aklylcyclohexanes: in vivo characterization. Amino Acids 2000; 19:167-172.
4. Parsons CG, Danysz W, Quack G. Memantine and the amino-alkyl-cyclohexane MRZ 2/579 are moderate affinity uncompetitive NMDA receptor antagonists: in vitro characterisation. Amino Acids 2000; 19:157-166.
5. Sinatra RS, Jahr JS, Reynolds LW, et al. Efficacy and safety of single and repeated administration of 1 gram intravenous acetaminophen injection (paracetamol) for pain management after major orthopedic surgery. Anesthesiology 2005; 102:822-831. This paper shows a new use for an old drug for postoperative pain control when it was mostly used for headache and temperature control in the past.
6. Nandi R, Fitzgerald M. Opioid analgesia in the newborn. Eur J Pain 2005; 9:105-108. This paper increases the awareness that the newborn can feel pain.
7. Sinatra RS, Shen QJ, Halaszynski T, et al. Preoperative rofecoxib oral suspension as an analgesic adjunct after lower abdominal surgery: the effects on effort-dependent pain and pulmonary function. Anesth Analg 2004; 98:135-140. This is an excellent review on the use of COX-2 inhibitors in the treatment of perioperative pain, which is more important than preemptive analgesia alone.
8. Desmond CP, Roberts SK. Exercise-related abdominal pain as a manifestation of the median arcuate ligament syndrome. Scand J Gastroenterol 2004; 39:1310-1313.
9. Ferrari R, Lang C. A cross-cultural comparison between Canada and Germany of symptom expectation for whiplash injury. J Spinal Disord Tech 2005; 18:92-97. With increase in travel there is an increased incidence of whiplash injuries. The expected symptoms and presentations are well discussed and will be useful to the practicing pain physician.
10. Perkins FM, Kehlet H. Chronic pain as an outcome of surgery. A review of predictive factors. Anesthesiology 2000; 93:1123-1133.
11. Ruscheweyh R, Sandkuhler J. Opioids and central sensitization: II. Induction and reversal of hyperalgesia. Eur J Pain 2005; 9:149-152. This paper outlines the roles of opioids in central sensitization as well as changes in the transition from acute to chronic state.
12. Giamberardino MA, Affaitati G, Lerza R, et al. Relationship between pain symptoms and referred sensory and trophic changes in patients with gallbladder pathology. Pain 2005; 114:239-249. Visceral pain with its characteristic referred changes and pathophysiology are explained well in this paper.
13. Nishida K, Doita M, Takada T, et al. Biological approach for treatment of degenerative disc diseases [in Japanese]. Clin Calcium 2005; 15:79-86.
14. Kawakami M. Pathophysiology of radicular pain [in Japanese]. Clin Calcium 2005; 15:57-62.
15. Senapati AK, Lagraize SC, Huntington PJ, et al. Electrical stimulation of the anterior cingulate cortex reduces responses of rat dorsal horn neurons to mechanical stimuli. J Neurophysiol 2005; 94:845-851. This basic research study is of extreme importance in designing motor cortex stimulating treatments.
16. Svendsen KB, Andersen S, Arnason S, et al. Breakthrough pain in malignant and non-malignant diseases: a review of prevalence, characteristics and mechanisms. Eur J Pain 2005; 9:195-206. This is an excellent review on breakthrough pain, not recognized well enough in the past.
17. Cheshire WP. Trigeminal neuralgia: diagnosis and treatment. Curr Neurol Neurosci Rep 2005; 5:79-85.
18. Zhuang ZY, Gerner P, Woolf CJ, Ji RR. ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain 2005; 114:149-159.
19. Harden RN. Chronic neuropathic pain. Mechanisms, diagnosis, and treatment. Neurologist 2005; 11:111-122. This paper highlights the latest understanding of neuropathic pain and changes centrally as well as peripherally.
20. von Spiczak S, Whone AL, Hammers A, et al. The role of opioids in restless legs syndrome: an [11C]diprenorphine PET study. Brain 2005; 128 (Pt 4):906-917.
21. Birklein F. Complex regional pain syndrome. J Neurol 2005; 252:131-138. The pathophysiology and the vast changes occurring in this difficult syndrome are discussed extremely well.
22. Yajima H, Sato J, Giron R, et al. Inhibitory, facilitatory, and excitatory effects of ATP and purinergic receptor agonists on the activity of rat cutaneous nociceptors in vitro. Neurosci Res 2005; 51:405-416.
23. Bitner RS, Nikkel AL, Curzon P, et al. Reduced nicotinic receptor-mediated antinociception following in vivo antisense knock-down in rat. Brain Res 2000; 871:66-74.
24. Fields RD, Lee PR, Cohen JE. Temporal integration of intracellular Ca(2+) signaling networks in regulating gene expression by action potentials. Cell Calcium 2005; 37:433-442. This is an excellent review of the mechanisms of pain regulation at the genetic level.
25. Zeitz KP, Guy N, Malmberg AB, et al. The 5-HT3 subtype of serotonin receptor contributes to nociceptive processing via a novel subset of myelinated and unmyelinated nociceptors. J Neurosci 2002; 22:1010-1019.
26. Macdonald G, Leary MR. Why does social exclusion hurt? The relationship between social and physical pain. Psychol Bull 2005; 131:202-223. This paper highlights the importance of multidisciplinary treatment for the treatment of chronic pain.
27. Panksepp J. Why does separation distress hurt? Comment on MacDonald and Leary (2005) Psychol Bull 2005; 131 (2):224-230; author reply 237-240.
28. Herraez-Baranda LA, Carretero J, Gonzalez-Sarmiento R, Rodriguez RE. Kappa opioid receptor is expressed in the rat cerebellar cortex. Cell Tissue Res 2005; 320:223-228.
29. Ossipov MH, Lai J, King T, et al. Underlying mechanisms of pronociceptive consequences of prolonged morphine exposure. Biopolymers 2005; 80:319-324. Opioid induced hyperalgesia has gained importance in recent years and this paper ties together the findings of numerous studies in this field.
30. Mitra S, Sinatra RS. Perioperative management of acute pain in the opioid-dependent patient. Anesthesiology 2004; 101:212-227. This is a comprehensive useful review for the treatment of the opioid dependent patient post-surgically.
31. Tawfik VL, Lacroix-Fralish ML, Nutile-McMenemy N, Deleo JA. Transcriptional and translational regulation of glial activation by morphine in a rodent model of neuropathic pain. J Pharmacol Exp Ther 2005; 313:1239-1247. This fascinating study revealed the genetic changes occurring during treatment in neuropathic pain.
32. Lotsch J, Geisslinger G. Are mu-opioid receptor polymorphisms important for clinical opioid therapy? Trends Mol Med 2005; 11:82-89. This paper increases the understanding of the molecular changes occurring in the presence of opioid therapy.